1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gram-positive Bacterial Infections Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 B-Lactam Antimicrobials 1.2.3 Fluoroquinolones 1.2.4 Penicillin 1.2.5 Cephalosporins 1.2.6 RNA Immunoprecipitation (RIP) 1.2.7 Vaccine 1.2.8 Other 1.3 Market by Application 1.3.1 Global Gram-positive Bacterial Infections Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gram-positive Bacterial Infections Market Perspective (2016-2027) 2.2 Gram-positive Bacterial Infections Growth Trends by Regions 2.2.1 Gram-positive Bacterial Infections Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gram-positive Bacterial Infections Historic Market Share by Regions (2016-2021) 2.2.3 Gram-positive Bacterial Infections Forecasted Market Size by Regions (2022-2027) 2.3 Gram-positive Bacterial Infections Industry Dynamic 2.3.1 Gram-positive Bacterial Infections Market Trends 2.3.2 Gram-positive Bacterial Infections Market Drivers 2.3.3 Gram-positive Bacterial Infections Market Challenges 2.3.4 Gram-positive Bacterial Infections Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gram-positive Bacterial Infections Players by Revenue 3.1.1 Global Top Gram-positive Bacterial Infections Players by Revenue (2016-2021) 3.1.2 Global Gram-positive Bacterial Infections Revenue Market Share by Players (2016-2021) 3.2 Global Gram-positive Bacterial Infections Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gram-positive Bacterial Infections Revenue 3.4 Global Gram-positive Bacterial Infections Market Concentration Ratio 3.4.1 Global Gram-positive Bacterial Infections Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gram-positive Bacterial Infections Revenue in 2020 3.5 Gram-positive Bacterial Infections Key Players Head office and Area Served 3.6 Key Players Gram-positive Bacterial Infections Product Solution and Service 3.7 Date of Enter into Gram-positive Bacterial Infections Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gram-positive Bacterial Infections Breakdown Data by Type 4.1 Global Gram-positive Bacterial Infections Historic Market Size by Type (2016-2021) 4.2 Global Gram-positive Bacterial Infections Forecasted Market Size by Type (2022-2027) 5 Gram-positive Bacterial Infections Breakdown Data by Application 5.1 Global Gram-positive Bacterial Infections Historic Market Size by Application (2016-2021) 5.2 Global Gram-positive Bacterial Infections Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gram-positive Bacterial Infections Market Size (2016-2027) 6.2 North America Gram-positive Bacterial Infections Market Size by Type 6.2.1 North America Gram-positive Bacterial Infections Market Size by Type (2016-2021) 6.2.2 North America Gram-positive Bacterial Infections Market Size by Type (2022-2027) 6.2.3 North America Gram-positive Bacterial Infections Market Size by Type (2016-2027) 6.3 North America Gram-positive Bacterial Infections Market Size by Application 6.3.1 North America Gram-positive Bacterial Infections Market Size by Application (2016-2021) 6.3.2 North America Gram-positive Bacterial Infections Market Size by Application (2022-2027) 6.3.3 North America Gram-positive Bacterial Infections Market Size by Application (2016-2027) 6.4 North America Gram-positive Bacterial Infections Market Size by Country 6.4.1 North America Gram-positive Bacterial Infections Market Size by Country (2016-2021) 6.4.2 North America Gram-positive Bacterial Infections Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Gram-positive Bacterial Infections Market Size (2016-2027) 7.2 Europe Gram-positive Bacterial Infections Market Size by Type 7.2.1 Europe Gram-positive Bacterial Infections Market Size by Type (2016-2021) 7.2.2 Europe Gram-positive Bacterial Infections Market Size by Type (2022-2027) 7.2.3 Europe Gram-positive Bacterial Infections Market Size by Type (2016-2027) 7.3 Europe Gram-positive Bacterial Infections Market Size by Application 7.3.1 Europe Gram-positive Bacterial Infections Market Size by Application (2016-2021) 7.3.2 Europe Gram-positive Bacterial Infections Market Size by Application (2022-2027) 7.3.3 Europe Gram-positive Bacterial Infections Market Size by Application (2016-2027) 7.4 Europe Gram-positive Bacterial Infections Market Size by Country 7.4.1 Europe Gram-positive Bacterial Infections Market Size by Country (2016-2021) 7.4.2 Europe Gram-positive Bacterial Infections Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gram-positive Bacterial Infections Market Size (2016-2027) 8.2 Asia-Pacific Gram-positive Bacterial Infections Market Size by Type 8.2.1 Asia-Pacific Gram-positive Bacterial Infections Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gram-positive Bacterial Infections Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gram-positive Bacterial Infections Market Size by Type (2016-2027) 8.3 Asia-Pacific Gram-positive Bacterial Infections Market Size by Application 8.3.1 Asia-Pacific Gram-positive Bacterial Infections Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gram-positive Bacterial Infections Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gram-positive Bacterial Infections Market Size by Application (2016-2027) 8.4 Asia-Pacific Gram-positive Bacterial Infections Market Size by Region 8.4.1 Asia-Pacific Gram-positive Bacterial Infections Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gram-positive Bacterial Infections Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gram-positive Bacterial Infections Market Size (2016-2027) 9.2 Latin America Gram-positive Bacterial Infections Market Size by Type 9.2.1 Latin America Gram-positive Bacterial Infections Market Size by Type (2016-2021) 9.2.2 Latin America Gram-positive Bacterial Infections Market Size by Type (2022-2027) 9.2.3 Latin America Gram-positive Bacterial Infections Market Size by Type (2016-2027) 9.3 Latin America Gram-positive Bacterial Infections Market Size by Application 9.3.1 Latin America Gram-positive Bacterial Infections Market Size by Application (2016-2021) 9.3.2 Latin America Gram-positive Bacterial Infections Market Size by Application (2022-2027) 9.3.3 Latin America Gram-positive Bacterial Infections Market Size by Application (2016-2027) 9.4 Latin America Gram-positive Bacterial Infections Market Size by Country 9.4.1 Latin America Gram-positive Bacterial Infections Market Size by Country (2016-2021) 9.4.2 Latin America Gram-positive Bacterial Infections Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gram-positive Bacterial Infections Market Size (2016-2027) 10.2 Middle East & Africa Gram-positive Bacterial Infections Market Size by Type 10.2.1 Middle East & Africa Gram-positive Bacterial Infections Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gram-positive Bacterial Infections Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gram-positive Bacterial Infections Market Size by Type (2016-2027) 10.3 Middle East & Africa Gram-positive Bacterial Infections Market Size by Application 10.3.1 Middle East & Africa Gram-positive Bacterial Infections Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gram-positive Bacterial Infections Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gram-positive Bacterial Infections Market Size by Application (2016-2027) 10.4 Middle East & Africa Gram-positive Bacterial Infections Market Size by Country 10.4.1 Middle East & Africa Gram-positive Bacterial Infections Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gram-positive Bacterial Infections Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Gram-positive Bacterial Infections Introduction 11.1.4 GlaxoSmithKline Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.1.5 GlaxoSmithKline Recent Development 11.2 Johnson & Johnson Inc. 11.2.1 Johnson & Johnson Inc. Company Details 11.2.2 Johnson & Johnson Inc. Business Overview 11.2.3 Johnson & Johnson Inc. Gram-positive Bacterial Infections Introduction 11.2.4 Johnson & Johnson Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.2.5 Johnson & Johnson Inc. Recent Development 11.3 Merck & Co. Inc. 11.3.1 Merck & Co. Inc. Company Details 11.3.2 Merck & Co. Inc. Business Overview 11.3.3 Merck & Co. Inc. Gram-positive Bacterial Infections Introduction 11.3.4 Merck & Co. Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.3.5 Merck & Co. Inc. Recent Development 11.4 Pfizer Inc. 11.4.1 Pfizer Inc. Company Details 11.4.2 Pfizer Inc. Business Overview 11.4.3 Pfizer Inc. Gram-positive Bacterial Infections Introduction 11.4.4 Pfizer Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.4.5 Pfizer Inc. Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Gram-positive Bacterial Infections Introduction 11.5.4 AstraZeneca Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 Astellas Pharma Inc. 11.6.1 Astellas Pharma Inc. Company Details 11.6.2 Astellas Pharma Inc. Business Overview 11.6.3 Astellas Pharma Inc. Gram-positive Bacterial Infections Introduction 11.6.4 Astellas Pharma Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.6.5 Astellas Pharma Inc. Recent Development 11.7 Novartis AG 11.7.1 Novartis AG Company Details 11.7.2 Novartis AG Business Overview 11.7.3 Novartis AG Gram-positive Bacterial Infections Introduction 11.7.4 Novartis AG Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.7.5 Novartis AG Recent Development 11.8 Sanofi SA 11.8.1 Sanofi SA Company Details 11.8.2 Sanofi SA Business Overview 11.8.3 Sanofi SA Gram-positive Bacterial Infections Introduction 11.8.4 Sanofi SA Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.8.5 Sanofi SA Recent Development 11.9 Sun Pharmaceutical Industries Ltd. 11.9.1 Sun Pharmaceutical Industries Ltd. Company Details 11.9.2 Sun Pharmaceutical Industries Ltd. Business Overview 11.9.3 Sun Pharmaceutical Industries Ltd. Gram-positive Bacterial Infections Introduction 11.9.4 Sun Pharmaceutical Industries Ltd. Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.9.5 Sun Pharmaceutical Industries Ltd. Recent Development 11.10 Cipla 11.10.1 Cipla Company Details 11.10.2 Cipla Business Overview 11.10.3 Cipla Gram-positive Bacterial Infections Introduction 11.10.4 Cipla Revenue in Gram-positive Bacterial Infections Business (2016-2021) 11.10.5 Cipla Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gram-positive Bacterial Infections Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of B-Lactam Antimicrobials Table 3. Key Players of Fluoroquinolones Table 4. Key Players of Penicillin Table 5. Key Players of Cephalosporins Table 6. Key Players of RNA Immunoprecipitation (RIP) Table 7. Key Players of Vaccine Table 8. Key Players of Other Table 9. Global Gram-positive Bacterial Infections Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Gram-positive Bacterial Infections Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Gram-positive Bacterial Infections Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Gram-positive Bacterial Infections Market Share by Regions (2016-2021) Table 13. Global Gram-positive Bacterial Infections Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Gram-positive Bacterial Infections Market Share by Regions (2022-2027) Table 15. Gram-positive Bacterial Infections Market Trends Table 16. Gram-positive Bacterial Infections Market Drivers Table 17. Gram-positive Bacterial Infections Market Challenges Table 18. Gram-positive Bacterial Infections Market Restraints Table 19. Global Gram-positive Bacterial Infections Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Gram-positive Bacterial Infections Market Share by Players (2016-2021) Table 21. Global Top Gram-positive Bacterial Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-positive Bacterial Infections as of 2020) Table 22. Ranking of Global Top Gram-positive Bacterial Infections Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Gram-positive Bacterial Infections Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Gram-positive Bacterial Infections Product Solution and Service Table 26. Date of Enter into Gram-positive Bacterial Infections Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Gram-positive Bacterial Infections Market Size by Type (2016-2021) (US$ Million) Table 29. Global Gram-positive Bacterial Infections Revenue Market Share by Type (2016-2021) Table 30. Global Gram-positive Bacterial Infections Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Gram-positive Bacterial Infections Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Gram-positive Bacterial Infections Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Gram-positive Bacterial Infections Revenue Market Share by Application (2016-2021) Table 34. Global Gram-positive Bacterial Infections Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Gram-positive Bacterial Infections Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Gram-positive Bacterial Infections Market Size by Type (2016-2021) (US$ Million) Table 37. North America Gram-positive Bacterial Infections Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Gram-positive Bacterial Infections Market Size by Application (2016-2021) (US$ Million) Table 39. North America Gram-positive Bacterial Infections Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Gram-positive Bacterial Infections Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Gram-positive Bacterial Infections Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Gram-positive Bacterial Infections Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Gram-positive Bacterial Infections Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Gram-positive Bacterial Infections Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Gram-positive Bacterial Infections Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Gram-positive Bacterial Infections Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Gram-positive Bacterial Infections Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Gram-positive Bacterial Infections Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Gram-positive Bacterial Infections Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Gram-positive Bacterial Infections Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Gram-positive Bacterial Infections Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Gram-positive Bacterial Infections Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Gram-positive Bacterial Infections Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Gram-positive Bacterial Infections Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Gram-positive Bacterial Infections Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Gram-positive Bacterial Infections Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Gram-positive Bacterial Infections Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Gram-positive Bacterial Infections Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Gram-positive Bacterial Infections Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Gram-positive Bacterial Infections Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Gram-positive Bacterial Infections Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Gram-positive Bacterial Infections Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Gram-positive Bacterial Infections Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Gram-positive Bacterial Infections Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Gram-positive Bacterial Infections Market Size by Country (2022-2027) & (US$ Million) Table 66. GlaxoSmithKline Company Details Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline Gram-positive Bacterial Infections Product Table 69. GlaxoSmithKline Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 70. GlaxoSmithKline Recent Development Table 71. Johnson & Johnson Inc. Company Details Table 72. Johnson & Johnson Inc. Business Overview Table 73. Johnson & Johnson Inc. Gram-positive Bacterial Infections Product Table 74. Johnson & Johnson Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 75. Johnson & Johnson Inc. Recent Development Table 76. Merck & Co. Inc. Company Details Table 77. Merck & Co. Inc. Business Overview Table 78. Merck & Co. Inc. Gram-positive Bacterial Infections Product Table 79. Merck & Co. Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 80. Merck & Co. Inc. Recent Development Table 81. Pfizer Inc. Company Details Table 82. Pfizer Inc. Business Overview Table 83. Pfizer Inc. Gram-positive Bacterial Infections Product Table 84. Pfizer Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 85. Pfizer Inc. Recent Development Table 86. AstraZeneca Company Details Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Gram-positive Bacterial Infections Product Table 89. AstraZeneca Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 90. AstraZeneca Recent Development Table 91. Astellas Pharma Inc. Company Details Table 92. Astellas Pharma Inc. Business Overview Table 93. Astellas Pharma Inc. Gram-positive Bacterial Infections Product Table 94. Astellas Pharma Inc. Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 95. Astellas Pharma Inc. Recent Development Table 96. Novartis AG Company Details Table 97. Novartis AG Business Overview Table 98. Novartis AG Gram-positive Bacterial Infections Product Table 99. Novartis AG Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 100. Novartis AG Recent Development Table 101. Sanofi SA Company Details Table 102. Sanofi SA Business Overview Table 103. Sanofi SA Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 104. Sanofi SA Recent Development Table 105. Sun Pharmaceutical Industries Ltd. Company Details Table 106. Sun Pharmaceutical Industries Ltd. Business Overview Table 107. Sun Pharmaceutical Industries Ltd. Gram-positive Bacterial Infections Product Table 108. Sun Pharmaceutical Industries Ltd. Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 109. Sun Pharmaceutical Industries Ltd. Recent Development Table 110. Cipla Company Details Table 111. Cipla Business Overview Table 112. Cipla Gram-positive Bacterial Infections Product Table 113. Cipla Revenue in Gram-positive Bacterial Infections Business (2016-2021) & (US$ Million) Table 114. Cipla Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Gram-positive Bacterial Infections Market Share by Type: 2020 VS 2027 Figure 2. B-Lactam Antimicrobials Features Figure 3. Fluoroquinolones Features Figure 4. Penicillin Features Figure 5. Cephalosporins Features Figure 6. RNA Immunoprecipitation (RIP) Features Figure 7. Vaccine Features Figure 8. Other Features Figure 9. Global Gram-positive Bacterial Infections Market Share by Application: 2020 VS 2027 Figure 10. Hospital Case Studies Figure 11. Clinic Case Studies Figure 12. Other Case Studies Figure 13. Gram-positive Bacterial Infections Report Years Considered Figure 14. Global Gram-positive Bacterial Infections Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Gram-positive Bacterial Infections Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Gram-positive Bacterial Infections Market Share by Regions: 2020 VS 2027 Figure 17. Global Gram-positive Bacterial Infections Market Share by Regions (2022-2027) Figure 18. Global Gram-positive Bacterial Infections Market Share by Players in 2020 Figure 19. Global Top Gram-positive Bacterial Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-positive Bacterial Infections as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Gram-positive Bacterial Infections Revenue in 2020 Figure 21. Global Gram-positive Bacterial Infections Revenue Market Share by Type (2016-2021) Figure 22. Global Gram-positive Bacterial Infections Revenue Market Share by Type (2022-2027) Figure 23. North America Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Gram-positive Bacterial Infections Market Share by Type (2016-2027) Figure 25. North America Gram-positive Bacterial Infections Market Share by Application (2016-2027) Figure 26. North America Gram-positive Bacterial Infections Market Share by Country (2016-2027) Figure 27. United States Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Gram-positive Bacterial Infections Market Share by Type (2016-2027) Figure 31. Europe Gram-positive Bacterial Infections Market Share by Application (2016-2027) Figure 32. Europe Gram-positive Bacterial Infections Market Share by Country (2016-2027) Figure 33. Germany Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Gram-positive Bacterial Infections Market Share by Type (2016-2027) Figure 41. Asia-Pacific Gram-positive Bacterial Infections Market Share by Application (2016-2027) Figure 42. Asia-Pacific Gram-positive Bacterial Infections Market Share by Region (2016-2027) Figure 43. China Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Gram-positive Bacterial Infections Market Share by Type (2016-2027) Figure 51. Latin America Gram-positive Bacterial Infections Market Share by Application (2016-2027) Figure 52. Latin America Gram-positive Bacterial Infections Market Share by Country (2016-2027) Figure 53. Mexico Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Gram-positive Bacterial Infections Market Share by Type (2016-2027) Figure 57. Middle East & Africa Gram-positive Bacterial Infections Market Share by Application (2016-2027) Figure 58. Middle East & Africa Gram-positive Bacterial Infections Market Share by Country (2016-2027) Figure 59. Turkey Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Gram-positive Bacterial Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. GlaxoSmithKline Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 63. Johnson & Johnson Inc. Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 64. Merck & Co. Inc. Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 65. Pfizer Inc. Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 66. AstraZeneca Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 67. Astellas Pharma Inc. Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 68. Novartis AG Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 69. Sanofi SA Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 70. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 71. Cipla Revenue Growth Rate in Gram-positive Bacterial Infections Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

GlaxoSmithKline Johnson & Johnson Inc. Merck & Co. Inc. Pfizer Inc. AstraZeneca Astellas Pharma Inc. Novartis AG Sanofi SA Sun Pharmaceutical Industries Ltd. Cipla